Log in or Sign up for Free to view tailored content for your specialty!
Hormone Therapy News
VIDEO: Three takeaways on cognition and brain health during menopause
CHICAGO — In this Healio video exclusive, Pauline M. Maki, PhD, provides three takeaways from her talk on cognition and hormone therapy during menopause at the Annual Meeting of The Menopause Society.
Voice changes, altered by hormone therapy, impact ‘at least one-third’ of menopausal women
CHICAGO — Voice and respiratory changes can impact women’s health during menopause and hormone therapy plays a role in helping or worsening these changes, according to a speaker at the Annual Meeting of The Menopause Society.
Clinicians ‘should be open’ to menopausal hormone therapy beyond age 65 years
CHICAGO — Hormone therapy is beneficial for some women beyond age 65 years to treat ongoing menopausal symptoms that affect their quality of life, according to research reported at the Annual Meeting of The Menopause Society.
Log in or Sign up for Free to view tailored content for your specialty!
New therapies for vaginal menopause symptoms may provide short-term relief
Vaginal estrogen, vaginal dehydroepiandrosterone, oral ospemifene and vaginal moisturizers result in short-term improvements in vaginal atrophy symptoms, known as genitourinary syndrome of menopause, but more long-term data are needed.
Hormone therapy use may slow biological aging for postmenopausal women
Postmenopausal women with a history of hormone therapy use were biologically younger compared with never-using counterparts, regardless of socioeconomic background, according to study results published in JAMA Network Open.
Transgender youths discuss social hostility, isolation due to gender-affirming care bans
Transgender youths discussed social concerns, facing hostility and being worried about losing access to care when interviewed about legislation prohibiting gender-affirming care, according to findings published in LGBT Health.
Hormone therapy for breast cancer may reduce dementia risk; benefit varies by age, race
Women with breast cancer who underwent hormone-modulating therapy exhibited a reduced risk for Alzheimer’s disease and related dementias, according to results of a retrospective cohort study.
Lack of providers, insurance denials among most common barriers to gender-affirming HT
Lack of available health care providers, health insurance exclusions and a lengthy assessment process are among barriers transgender people face when seeking gender-affirming hormone therapy, according to study findings.
Primary ovarian insufficiency, reproductive cancers may be linked across generations
BOSTON — People with primary ovarian insufficiency have higher risk for breast cancer and borderline increased risk for ovarian cancer compared with the general population, and risks for some cancers extend to their relatives, data show.
Menopause may unmask vulnerability to Alzheimer’s disease, other dementias
BOSTON — Menopause is a neurologic transition involving metabolic and immune systems of the brain, and timely estrogen therapy could reduce the risk for developing dementias and other neurogenerative diseases, according to a speaker.
-
Headline News
‘The mind is medicine’: How virtual reality can cool bothersome hot flashes
September 18, 20244 min read -
Headline News
CDC: Close contact of Missouri bird flu case had symptoms but was not tested
September 17, 20242 min read -
Headline News
Metformin use may lower risk for long COVID in adults with type 2 diabetes
September 18, 20243 min read
-
Headline News
‘The mind is medicine’: How virtual reality can cool bothersome hot flashes
September 18, 20244 min read -
Headline News
CDC: Close contact of Missouri bird flu case had symptoms but was not tested
September 17, 20242 min read -
Headline News
Metformin use may lower risk for long COVID in adults with type 2 diabetes
September 18, 20243 min read